383
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Safeguarding innovation through an economic downturn

Pages 347-349 | Published online: 09 Jan 2014
 

Financial & competing interests disclosure

The author is the Director General of the Association of the British Pharmaceutical Industry (ABPI). The ABPI is the trade association for the UK research-based pharmaceutical industry, representing companies both small and large. Member companies research, develop, manufacture and supply more than 80% of the medicines prescribed through the National Health Service (NHS).

No writing assistance was utilized in the production of this manuscript.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.